| FARICIMAB |
Vabysmo® |
Roche Products Pty Ltd |
Diabetic Macular Oedema (DMO) |
May 2022 |
Recommended |
| FARICIMAB |
Vabysmo® |
Roche Products Pty Ltd |
Neo-vascular (wet) Age-related Macular Degeneration (nAMD) |
May 2022 |
Recommended |
| PREGABALIN |
Lyrica® CR |
Upjohn Australia Pty Ltd |
Neuropathic pain |
May 2022 |
Not Recommended |
| DARATUMUMAB |
Darzalex SC® |
Janssen-Cilag Pty Ltd |
Amyloid light-chain (AL) amyloidosis |
May 2022 |
Recommended |
| TRIENTINE |
Cuprior® |
Orphalan |
Wilson disease |
May 2022 |
Recommended |
| PREGABALIN |
Pregabalin-AFT |
AFT Pharmaceuticals (Au) Pty Ltd |
Neuropathic pain |
May 2022 |
Not Recommended |
| DULAGLUTIDE |
Trulicity® |
Eli Lilly Australia Pty Ltd |
Type 2 diabetes mellitus |
May 2022 |
Recommended |
| TRIENTINE |
Waymade® |
Clinect Pty Ltd |
Wilson disease |
May 2022 |
Recommended |
| APREMILAST |
Otezla® |
Amgen Australia Pty Limited |
Severe chronic plaque psoriasis |
May 2022 |
Recommended |
| PEMBROLIZUMAB |
Keytruda® |
Merck Sharp & Dohme (Australia) Pty Ltd |
Gastro-oesophageal cancers |
May 2022 |
Recommended |
| BUROSUMAB |
Crysvita® |
Kyowa Kirin Australia Pty Ltd |
X-linked hypophosphataemia |
May 2022 |
Recommended |
| ELTROMBOPAG |
Revolade® |
Novartis Pharmaceuticals Australia Pty Limited |
Thrombopoietin receptor agonists (TPO-RAs) for primary immune thrombocytopenia (ITP) |
May 2022 |
Recommended |
| ROMIPLOSTIM |
Nplate® |
Amgen Australia Pty Limited |
Thrombopoietin receptor agonists (TPO-RAs) for primary immune thrombocytopenia (ITP) |
May 2022 |
Recommended |
| BECLOMETASONE WITH FORMOTEROL AND GLYCOPYRRONIUM |
Trimbow® |
Chiesi Australia Pty Ltd |
Asthma |
May 2022 |
Recommended |